Pre Next

[1] WANG Wenfang WANG Yafeng LI Liuyun DANG Huimin MA Yan CUI Xiaoqing AN Peng,.Professor LIU Yanqiao’s Experience in Treating Polycystic Ovary Syndrome by “Menstruation Stage” [J]. Modern Traditional Chinese Medicine, 2022, 1(06): 82-85. [doi: 10.13424/j.cnki.mtcm.2022.06.016]

Copy

Professor LIU Yanqiao’s Experience in Treating Polycystic Ovary Syndrome by “Menstruation Stage”

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 1 2022 06 pagination: 82-85 Column: Publication date: 2022-12-10

Article number:: 1672-0571(2022)06-0082-04

Author(s):: WANG Wenfang WANG Yafeng LI Liuyun DANG Huimin MA Yan CUI Xiaoqing AN Peng; The Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an 710004,China

Keywords:: Key words:LIU Yanqiao; Polycystic ovary syndrome; Menstrual adjustment by stages; Clinical experience

ZTFLH:: R271.9

DOI:: 10.13424/j.cnki.mtcm.2022.06.016

Code:: A

Abstract:: Abstract：Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder disease in clinic, which belongs to the category of “amenorrhea” and “infertility” in traditional Chinese medicine. Professor LIU Yanqiao has rich experience and unique opinions in treating this disease, and believes that the underlying disease is due to the lack of natural origin, and the acquired bad emotions and dietary factors are the predisposing factors; Kidney deficiency is the basic pathogenesis of the disease, liver depression and Qi stagnation are the pivot of the pathogenesis, which also includes blood stasis and phlegm; In clinical practice, “regulate menstruation by stages” and “use acupuncture and medicine simultaneously”, and regulating drugs according to the body constitution. This article describes Professor LIU’s clinical experience in treating polycystic ovary syndrome, hoping to share it with the majority of TCM colleagues.

References:

［1］Trakakis E,Loghis C,Kassanos D.Congenital adrenal hyperplasia because of 21-hydroxylase deficiency.A genetic disorder of interest to obstetricians and gynecologists［J］.Obstetrical & Gynecological Survey,2009,64(3):177-189.
［2］谢幸,孔北华,段涛.妇产科学［M］.9版.北京:人民卫生出版社,2018.
［3］姜晓琳,张兵,侯海燕,等.二甲双胍联合膈下逐瘀汤对多囊卵巢综合征大鼠炎性因子及性激素水平的影响［J］.北京中医药大学学报,2018,41(1):65-70.
［4］葛彦,王克华,查玉桃,等.丹栀逍遥丸辅助治疗肝郁化火型多囊卵巢综合征疗效的Meta分析［J］.中华中医药学刊,2018,36(1):67-70.
［5］郭仪青,董慧.中医辨证分型治疗多囊卵巢综合征的研究进展［J］.中西医结合研究,2017,9(6):314-316,319.
［6］张红阳,侯丽辉,孙淼.多囊卵巢综合征患者西医亚型与中医证型的相关研究［J］.现代中西医结合杂志,2019,28(17):1829-1833.
［7］王波,闫巍,侯丽辉,等.多囊卵巢综合征生殖障碍表现为天癸失序［J］.中西医结合学报,2010,8(11):1018-1022.
［8］王金鸾,牛爱菊,张宁.多囊卵巢综合征伴发焦虑、抑郁状态的中医证型与压力来源分析［J］.中西医结合研究,2021,13(1):14-18.
［9］许洋,张浩琳,王传社,等.情志因素影响多囊卵巢综合征发生发展的研究进展［J］.中华中医药杂志,2019,34(9):4193-4196.
［10］郑艳.肥胖型多囊卵巢综合征患者临床特征分析［J］.中国现代药物应用,2015,9(3):57-58.
［11］刘颖华,侯丽辉,郝松莉,等.名老中医治疗多囊卵巢综合征的用药规律研究［J］.中国中医基础医学杂志,2016,22(4):537-538,547.
［12］柯龙升.丹栀逍遥丸联合西药治疗多囊卵巢综合征(PCOS)多中心随机平行对照研究［J］.实用中医内科杂志,2016,30(11):79-82.
［13］黄茹蓓,田丽颖.中医疗法对多囊卵巢综合征激素水平影响的研究进展［J］.亚太传统医药,2018,14(1):71-73.
［14］刘伟伟.多囊卵巢综合征的中医诊疗进展［J］.光明中医,2018,33(4):592-594.
［15］吴杭翡.丹栀逍遥胶囊对肝郁化火型多囊卵巢综合征促排卵的作用分析［J］.实用妇科内分泌电子杂志,2019,6(35):71-73,116.
［16］刘艳巧.刘润侠教授治疗多囊卵巢综合征不孕的学术思想和临床经验研究［D］.北京:中国中医科学院,2012.
［17］Stener-victorin E,waldenstrm U,Tgnfors U,et al.Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome［J］.Acta Obstetricia et Gynecologica Scandinavica,2000,79(3):180-188.
［18］俞瑾.多囊卵巢综合征的中西医治疗［J］.中国实用妇科与产科杂志,2002,18(11):651-653.
［19］陈晟,王军,赵吉平,等.对中医针灸临床研究中二则问题的思考［J］.上海针灸杂志,2017,36(7):886-889.
［20］饶龙,朱虹丽.从脾肾论治多囊卵巢综合征的研究进展［J］.中医文献杂志,2019,37(2):70-72.

Memo

基金项目：刘润侠全国名老中医药专家传承工作室建设项目（国中医药人教函〔2019〕41号）；陕西省中医药管理局科研课题（2019-ZZ-QT001）；陕西省中医药管理局科研课题（2019-ZZ-JC033）

Last Update: 2022-11-28